Oracle Corp: Form 10-Q for the period ended Nov 30, 2024
Filed with the SEC on Dec 10, 2024 and accepted by EDGAR at Dec 10, 2024, 16:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-09-01 to 2024-11-30 | $14.06bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-06-01 to 2024-11-30 | $27.37bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2024-09-01 to 2024-11-30 | $2.47bn | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-06-01 to 2024-11-30 | $4.78bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-09-01 to 2024-11-30 | $4.22bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-06-01 to 2024-11-30 | $8.21bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-09-01 to 2024-11-30 | $866.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2024-06-01 to 2024-11-30 | $1.71bn | us-gaap:InterestExpense |
| Income tax | 3 months2024-09-01 to 2024-11-30 | $239.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-06-01 to 2024-11-30 | $480.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-09-01 to 2024-11-30 | $3.15bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-06-01 to 2024-11-30 | $6.08bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-09-01 to 2024-11-30 | $1.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-06-01 to 2024-11-30 | $2.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-09-01 to 2024-11-30 | $1.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-06-01 to 2024-11-30 | $2.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-09-01 to 2024-11-30 | 2,869,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-06-01 to 2024-11-30 | 2,860,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-06-01 to 2024-11-30 | $8.73bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-06-01 to 2024-11-30 | $6.27bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2024-06-01 to 2024-11-30 | $2.22bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2024-06-01 to 2024-11-30 | $300.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-11-30 | $10.94bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-11-30 | $23.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-11-30 | $148.48bn | us-gaap:Assets |
| Current liabilities | At period end2024-11-30 | $29.05bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-11-30 | $13.75bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-12-06 | 2,796,956,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-134973. Last ingested by Listed: Oct 27, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.